Nephrogenic systemic fibrosis, kidney disease, and gadolinium: is there a link?

Editorial

Mark A Perazella. Clin J Am Soc Nephrol. 2007 Mar.

. 2007 Mar;2(2):200-2.

doi: 10.2215/CJN.00030107. Epub 2007 Feb 7.

No abstract available

Comment on

Nephrogenic systemic fibrosis: a mysterious disease in patients with renal failure--role of gadolinium-based contrast media in causation and the beneficial effect of intravenous sodium thiosulfate.
Yerram P, Saab G, Karuparthi PR, Hayden MR, Khanna R. Yerram P, et al. Clin J Am Soc Nephrol. 2007 Mar;2(2):258-63. doi: 10.2215/CJN.03250906. Epub 2007 Feb 7. Clin J Am Soc Nephrol. 2007. PMID: 17699422
Nephrogenic systemic fibrosis: a population study examining the relationship of disease development to gadolinium exposure.
Deo A, Fogel M, Cowper SE. Deo A, et al. Clin J Am Soc Nephrol. 2007 Mar;2(2):264-7. doi: 10.2215/CJN.03921106. Epub 2007 Feb 7. Clin J Am Soc Nephrol. 2007. PMID: 17699423